1-10 of 10
Lulu Lv
Close
Sort by
Journal Articles

Long-Term Activity of Combining CNCT19 with HDT/ASCT in Refractory Large B-Cell Lymphoma: Two-Year Follow-up of a Prospective Phase 1/2 Clinical Trial

Wei Liu, Hesong Zou, Yan Xu, Huimin Liu, Chenxing Du, Rui Lv, Wenyang Huang, Weiwei Sui, Shuhua Yi, Lulu Lv, Lugui Qiu, Jianxiang Wang, Dehui Zou
Journal: Blood
Blood (2022) 140 (Supplement 1): 7472–7473.
https://doi.org/10.1182/blood-2022-166451
Published: 2022
Journal Articles

CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study

Wei Liu, Wenyang Huang, Rui Lv, Huimin Liu, Shuhua Yi, Hong Liu, Lulu Lv, Lugui Qiu, Jianxiang Wang, Dehui Zou
Journal: Blood
Blood (2022) 140 (Supplement 1): 4598–4599.
https://doi.org/10.1182/blood-2022-167104
Published: 2022
Journal Articles

Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies

Yu Zhang, Ying Wang, Runxia Gu, Lin Shi, Yongzeng Wang, Yi Feng, Lulu Lv, Qing Rao, Min Wang, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 630–631.
https://doi.org/10.1182/blood-2022-162345
Published: 2022
Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 1598–1600.
https://doi.org/10.1182/blood-2022-165002
Published: 2022
Journal Articles

CNCT19 for Treatment of Patients with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-cell ALL) in Children and Adults

Ying Wang, Xiaojuan Chen, Shuning Wei, Yingchang Mi, Lin Shi, Ying Wang, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Xiaofan Zhu, Jianxiang Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2811.
https://doi.org/10.1182/blood-2021-145272
Published: 2021
Journal Articles

Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Wei Liu, Wenyang Huang, Ryu Lv, Shuhui Deng, MD, Shuhua Yi, MD, Huimin Liu, Lulu Lv, Lugui Qiu, MD, Dehui Zou, MD, Jianxiang Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2.
https://doi.org/10.1182/blood-2020-139351
Published: 2020
Journal Articles

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Wei Liu, Rui Lv, Wenyang Huang, Hong Liu, Shuhui Deng, MD, Shuhua Yi, MD, Lulu Lv, Jianxiang Wang, MD, Lugui Qiu, MD PhD, Dehui Zou, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2913.
https://doi.org/10.1182/blood-2019-126635
Published: 2019
Journal Articles

Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia

Runxia Gu, Fang Liu, Dehui Zou, MD, Bingcheng Liu, Wei Liu, Xiaojuan Chen, MD, Kaiqi Liu, Ye Guo, MD, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Yingxi Xu, Huijun Wang, Hui Wei, MD, Yingchang Mi, MD, Lugui Qiu, MD PhD, Lulu Lv, Min Wang, MD, Ying Wang, MD, Xiaofan Zhu, MD, Jianxiang Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2622.
https://doi.org/10.1182/blood-2019-125342
Published: 2019
Journal Articles

In Vitro Induction of Anti-Leukemia CTL Effect by Dendritic Cells Infected with Recombinant Adenovirus Vectors Containing Human Survivin Genes.

Xiongpeng Zhu, Jianda Hu, Xu Lin, Ting Yang, MD, Zhengshu Xu, MD, Lulu Lv, Chuntuan Li, Zhizhe Chen
Journal: Blood
Blood (2006) 108 (11): 5483.
https://doi.org/10.1182/blood.V108.11.5483.5483
Published: 2006
Journal Articles

Stromal Cell Line Enhances Survival of Myeloid Leukemia Cells by Regulating the Expression of bcl-2 Family Genes and Caspase-3.

Zhenshu Xu, MD, Yongjun Liu, Zhibo Han, Lulu Lv, Ting Yang, MD, Rui He, Zhizhe Chen, Zhongchao Han
Journal: Blood
Blood (2006) 108 (11): 4498.
https://doi.org/10.1182/blood.V108.11.4498.4498
Published: 2006